Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV

BACKGROUND: As the use of Integrase inhibitor (INSTI)-class antiretroviral medications becomes more common to maintain long-term viral suppression, early reports suggest the potential for CNS side-effects when starting or switching to an INSTI-based regimen. In a population already at higher risk fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Behav
Main Authors: Kamkwalala, Asante R., Wang, Kunbo, O’Halloran, Jane, Williams, Dionna W., Dastgheyb, Raha, Fitzgerald, Kathryn C., Spence, Amanda B., Maki, Pauline M., Gustafson, Deborah R., Milam, Joel, Sharma, Anjali, Weber, Kathleen M., Adimora, Adaora A., Ofotokun, Igho, Sheth, Anandi N., Lahiri, Cecile D., Fischl, Margaret A., Konkle-Parker, Deborah, Xu, Yanxun, Rubin, Leah H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948485/
https://ncbi.nlm.nih.gov/pubmed/32638219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-020-02967-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados